Danish educational materials
From November 15th 2016 the Danish Medicines Agency published Danish educational materials for human medicinal products approved via the national procedure, the mutual recognition procedure and the decentralised procedure.
From January 1st 2023 and forward – and not retroactively - the Danish Medicines Agency also publishes Danish educational materials for human medicinal products approved via the centralised procedure.
The marketing authorisation holder has the overall responsibility for the educational material and for ensuring that it complies with the conditions of the marketing authorisation. The marketing authorisation holder also has the overall responsibility for ensuring that the Danish Medicines Agency has the latest accepted written educational material available for publication.
Please refer to the section Dansk uddannelsesmateriale for the accepted and published Danish educational materials
| Name | Medicine Type | Strength | Active substance | Mft owner | Publish Date |
| Emthexate | tabletter | 2,5 mg | METHOTREXATNATRIUM | Teva B.V. | 14/07/2022 |
| Emtricitabin/Tenofovirdisoproxil "Tillomed" | filmovertrukne tabletter | 200+245 mg | EMTRICITABIN, TENOFOVIRDISOPROXILFUMARAT | Tillomed Pharma GmbH | 26/08/2024 |
| Emtricitabine/Tenofovir disoproxil "Accordpharma" | filmovertrukne tabletter | 200+245 mg | EMTRICITABIN, TENOFOVIRDISOPROXILFUMARAT | Accord Healthcare B.V. | 04/03/2024 |
| Emtricitabine/Tenofovir disoproxil "Glenmark" | filmovertrukne tabletter | 200+245 mg | EMTRICITABIN, Tenofovir disoproxilphosphat | Glenmark Arzneimittel GmbH | 14/08/2020 |
| Emtricitabine/Tenofovir disoproxil "Mylan" | filmovertrukne tabletter | 200+245 mg | EMTRICITABIN, Tenofovir Disoproxil maleat | Mylan Pharmaceuticals Limited | 02/10/2023 |
| Emtricitabine/Tenofovir disoproxil "Teva" | filmovertrukne tabletter | 200+245 mg | EMTRICITABIN, Tenofovir disoproxilphosphat | Teva B.V. | 10/07/2017 |
| Emtricitabine/Tenofovir disoproxil "Zentiva" | filmovertrukne tabletter | 200+245 mg | EMTRICITABIN, Tenofovir disoproxilphosphat | Zentiva k.s. | 29/11/2024 |
| Enalaprilmaleat/Lercanidipinhydrochlorid "Stada Arzneimittel AG" | filmovertrukne tabletter | 10+10 mg | ENALAPRILMALEAT, LERCANIDIPINHYDROCHLORID | STADA Arzneimittel AG | 06/07/2017 |
| Enalaprilmaleat/Lercanidipinhydrochlorid "Stada Arzneimittel AG" | filmovertrukne tabletter | 20+10 mg | ENALAPRILMALEAT, LERCANIDIPINHYDROCHLORID | STADA Arzneimittel AG | 06/07/2017 |
| Enbrel | injektionsvæske, opløsning i fyldt injektionssprøjte | 25 mg | ETANERCEPT | Pfizer Europe MA EEIG | 09/03/2026 |
| Enbrel | injektionsvæske, opløsning i fyldt injektionssprøjte | 50 mg | ETANERCEPT | Pfizer Europe MA EEIG | 09/03/2026 |
| Enbrel | injektionsvæske, opløsning i fyldt pen | 50 mg | ETANERCEPT | Pfizer Europe MA EEIG | 09/03/2026 |
| Enbrel | pulver og solvens til injektionsvæske, opløsning | 50 mg | ETANERCEPT | Pfizer Ltd | 09/03/2026 |
| Enbrel | pulver og solvens til injektionsvæske, opløsning | 25 mg | ETANERCEPT | Pfizer Europe MA EEIG | 09/03/2026 |
| Enbrel | pulver til injektionsvæske, opløsning | 50 mg | ETANERCEPT | Pfizer Europe MA EEIG | 09/03/2026 |
| Enbrel | pulver til injektionsvæske, opløsning | 25 mg | ETANERCEPT | Pfizer Europe MA EEIG | 09/03/2026 |
| Enbrel til pædiatrisk brug | pulver og solvens til injektionsvæske, opløsning | 25 mg | ETANERCEPT | Pfizer Ltd | 09/03/2026 |
| Enbrel til pædiatrisk brug | pulver og solvens til injektionsvæske, opløsning | 10 mg | ETANERCEPT | Pfizer Europe MA EEIG | 09/03/2026 |
| Enjaymo | infusionsvæske, opløsning | 50 mg/ml | Sutimlimab | Recordati Rare Diseases | 22/04/2025 |
| Enwylma | injektionsvæske, opløsning | 120 mg | Denosumab | Zentiva k.s. | 17/11/2025 |
| EpiPen | injektionsvæske, opløsning | 300 mikrogram | ADRENALIN | Viatris ApS | 12/07/2022 |
| EpiPen Jr. | injektionsvæske, opløsning | 150 mikrogram | ADRENALIN | Viatris ApS | 12/07/2022 |
| Epysqli | koncentrat til infusionsvæske, opløsning | 300 mg | Eculizumab | Samsung Bioepis NL B.V. | 24/06/2024 |